Abattis Bioceuticals Corp. (ATTBF)

[GreenBrickRoad]

Point taken, and long term they do need to show cash flow. But let's not forget that the first run-up in 2014 to $2.00+ occurred without the glistening positive numbers.

I do think enough of the potential buyers this time around learned their hard lessons from 2014. So ATTBF is not likely to return to $1-2 without the cash flow to justify it. But as others have mentioned, $0.50 or so is not out of the question if they keep showing progress.